Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic TPO with BMS-IMRT in Esophageal Cancer
NCT05944809Phase 2Completed
- Start
- Jul 2023
- Primary completion
- Jun 2024
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human thrombopoietin in Thrombocytopenia. Started Jul 2023; status: completed.
02
Drugs
recombinant human thrombopoietin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT05944809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05944809.